- Home
- IFS vs RNA Comparison
IFS vs RNA Comparison
Compare IFS & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IFS | RNA |
|---|---|---|
| Founded | 1897 | 2012 |
| Country | Peru | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.0B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IFS | RNA |
|---|---|---|
| Price | $45.17 | $72.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 20 |
| Target Price | $48.00 | ★ $69.26 |
| AVG Volume (30 Days) | 160.6K | ★ 1.9M |
| Earning Date | 02-10-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.11% | N/A |
| EPS Growth | ★ 81.66 | N/A |
| EPS | ★ 5.02 | N/A |
| Revenue | ★ $1,581,287,530.00 | $20,868,000.00 |
| Revenue This Year | N/A | $88.12 |
| Revenue Next Year | $3.75 | $18.11 |
| P/E Ratio | $8.94 | ★ N/A |
| Revenue Growth | 33.10 | ★ 106.27 |
| 52 Week Low | $28.74 | $21.51 |
| 52 Week High | $45.99 | $72.70 |
Technical Indicators
Market Signals| Indicator | IFS | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 69.48 | 72.72 |
| Support Level | $44.61 | $72.23 |
| Resistance Level | $45.99 | $72.70 |
| Average True Range (ATR) | 1.01 | 0.17 |
| MACD | 0.19 | -0.14 |
| Stochastic Oscillator | 83.72 | 74.29 |
Price Performance
Historical ComparisonAbout IFS Intercorp Financial Services Inc.
Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services and payments for retail customers and commercial clients in Peru. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services. Its geographical segments include Peru and Panama.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.